Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash & Equivalents (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Cash & Equivalents for 4 consecutive years, with $2.5 billion as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Cash & Equivalents fell 3.47% year-over-year to $2.5 billion, compared with a TTM value of $2.5 billion through Mar 2025, down 3.47%, and an annual FY2024 reading of $2.9 billion, up 15.44% over the prior year.
  • Cash & Equivalents was $2.5 billion for Q1 2025 at GE HealthCare Technologies, down from $2.9 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.6 billion in Q3 2024 and bottomed at $504.0 million in Q3 2022.
  • Average Cash & Equivalents over 4 years is $2.0 billion, with a median of $2.3 billion recorded in 2023.
  • The sharpest move saw Cash & Equivalents surged 380.16% in 2023, then fell 3.47% in 2025.
  • Year by year, Cash & Equivalents stood at $1.5 billion in 2022, then skyrocketed by 72.71% to $2.5 billion in 2023, then rose by 15.44% to $2.9 billion in 2024, then fell by 14.41% to $2.5 billion in 2025.
  • Business Quant data shows Cash & Equivalents for GEHC at $2.5 billion in Q1 2025, $2.9 billion in Q4 2024, and $3.6 billion in Q3 2024.